2031年体外二氧化碳去除装置市场报告(细分市场、地域、动态、最新发展及战略洞察)

  • Report Code : TIPMD00002259
  • Category : Life Sciences
  • No. of Pages : 150
立即购买

体外二氧化碳去除装置市场预计将从 2024 年的 1.125 亿美元增长到 2031 年的 1.8436 亿美元;预计 2025-2031 年期间该市场的复合年增长率为 6.4%。

市场洞察和分析师观点:

慢性阻塞性肺病 (COPD) 病例的增加以及老年人口的增长等因素推动了体外二氧化碳去除装置市场的增长。然而,与体外二氧化碳去除装置相关的严格规定阻碍了市场的增长。

体外二氧化碳去除装置安全、有效、可行。临床上建议使用体外二氧化碳去除装置进行呼吸支持,可能有助于缓解 COPD 和急性呼吸窘迫综合征的恶化。多家制造商致力于开发技术先进、创新的体外二氧化碳去除装置,加强其市场地位。此外,越来越多易患 COPD 的老年人被插入体外二氧化碳去除装置,以提高他们的存活率。因此,肺阻塞性疾病发病率的上升是导致体外二氧化碳去除装置市场规模不断扩大的因素之一。相反,使用体外二氧化碳去除装置存在感染、低氧血症或血栓形成的风险,因为循环系统血流受限会导致严重的健康问题,并对市场扩张构成长期挑战。

增长动力:

慢性阻塞性肺病病例增加 推动体外二氧化碳去除装置市场

根据2019年的疾病负担研究,全球记录了2.123亿例慢性阻塞性肺病(COPD)病例和330万例COPD相关死亡病例。COPD等呼吸系统疾病的主要原因之一是日益严重的空气污染。此外,经济合作与发展组织(OECD)指出,预计到2050年,全球温室气体排放量将激增约50%,原因是二氧化碳排放量将增加到70%。此外,OECD估计,到2050年,大气中温室气体浓度可能达到二氧化碳当量的685ppm(百万分之685),这将导致平均气温比工业化前水平上升3-6°C。

2021 年 1 月发表在 PLoS ONE 杂志上的一项研究显示,法国约有 260 万人患有 COPD。到 2025 年,这一数字预计将上升到 280 万。根据国家健康科学发布的 2022 年统计数据,2020-21 年英国约有 117 万人被诊断患有 COPD,占总人口的 1.9%。世界卫生组织表示,COPD 是全球第三大死亡原因,2022 年导致约 320 万人死亡。此外,美国肺脏协会的数据显示,美国每年有超过 1100 万人被诊断患有 COPD。因此,人群中 COPD 的高负担增加了对体外二氧化碳去除装置的需求,以促进血流和高效气体交换,从而推动体外二氧化碳去除装置市场的增长。

定制此报告以满足您的要求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

体外二氧化碳去除装置市场:

Extracorporeal CO2 Removal Devices Market
  • 获取此报告的顶级关键市场趋势。
    此免费样品将包括数据分析,从市场趋势到估计和预测。

报告细分和范围:

“体外二氧化碳去除装置市场分析”是通过考虑以下几个部分进行的:产品、应用和最终用户。

节段分析:

根据应用,体外二氧化碳去除装置市场可细分为急性呼吸窘迫综合征 (ARDS)、慢性阻塞性肺病 (CPD) 和其他疾病。慢性阻塞性肺病领域在 2022 年占据了最大的市场份额。预计急性呼吸窘迫综合征 (ARDS) 领域在预测期内的复合年增长率最高,为 7.7%。随着人们对 ARDS 及其早期发现的认识不断提高,越来越多的患者得到了诊断和治疗,这导致针对 ARDS 管理的体外二氧化碳去除装置的需求也随之增加。因此,医疗保健提供者对将体外二氧化碳去除装置纳入其 ARDS 治疗方案的信心也随之增强。

体外二氧化碳去除装置可以降低呼吸频率和潮气量,从而延长呼气时间,更好地适应呼吸系统较高的呼气时间常数。根据英国肺脏协会的数据,英国约有120万人被确诊患有慢性阻塞性肺病 (COPD)。因此,预计COPD患病率的上升将加速全球体外二氧化碳去除装置市场的发展。

体外二氧化碳去除设备市场按产品分为体外二氧化碳设备和耗材。2022年,体外二氧化碳设备领域占据了较大的市场份额。预计在预测期内,耗材领域的复合年增长率将达到7.6%。由于技术简化,体外二氧化碳去除装置所需人员和物流较少,从而增加了患者的选择。这使得体外二氧化碳去除装置领域稳固了其市场地位。

体外二氧化碳去除过程需要为每位患者提供一套全新的耗材,因此各种慢性阻塞性肺疾病 (COPD) 和急性呼吸窘迫综合征 (ARDS) 相关手术对耗材的需求很高。因此,预计体外二氧化碳去除设备耗材市场在预测期内将继续增长。

按最终用户划分,市场分为医院和诊所、门诊手术中心和其他。医院和诊所在2022年占据了体外二氧化碳去除设备最大的市场份额,预计在预测期内将实现7.4%的最高复合年增长率。医院,尤其是配备专门重症监护病房 (ICU) 和呼吸科的医院,拥有救治重症患者的设备。此外,医院通常拥有由多学科医疗专业人员组成的团队,包括肺科医生、重症监护医生、呼吸治疗师和灌注师,他们共同努力治疗有复杂呼吸需求的患者。这些专业知识对于安全有效地使用ECCO2R设备至关重要。

不断进步的技术加速体外二氧化碳去除装置市场的发展

体型较小的体外二氧化碳去除装置对患者创伤更小,也更舒适。它们通常需要更小的血管通路,从而降低并发症风险。由于患者不再受大型、无法移动的装置的束缚,他们可以体验到更大的活动性和舒适度,从而提高整体治疗质量。膜技术的进步显著提高了体外二氧化碳去除装置的有效性和功效。它们选择性地允许二氧化碳扩散,同时保留重要的血液成分,例如红细胞和蛋白质。这种选择性最大限度地降低了溶血和其他血液相关并发症的风险。

由于老年人健康状况的恶化,维持生活质量的需求日益增加,体外二氧化碳去除装置在提供微创、更温和的呼吸支持方面发挥着重要作用。体外二氧化碳去除 (ECCO2R) 的技术进步推动了更加用户友好和便携设备的开发。随着其益处日益得到认可,ECCO2R 越来越多地被纳入老年人的治疗计划中。因此,持续的技术进步可能会在未来几年带来新的体外二氧化碳去除装置市场趋势。

区域分析:

体外二氧化碳去除装置市场报告的范围包括北美、欧洲、亚太、南美和中美以及中东和非洲。

2022年,北美占据了最大的体外二氧化碳去除设备市场份额。该地区市场的增长得益于医疗基础设施的改善和体外二氧化碳去除设备的广泛采用,尤其是在美国和加拿大的新冠疫情期间。新技术的早期采用以及大量的急性呼吸窘迫综合征 (ARDS) 和慢性阻塞性肺病 (COPD) 患者群体预计将加速该地区市场的增长。慢性呼吸系统疾病发病率的上升以及对安全快速的微创呼吸机的偏好,预计将在预测期内进一步加速体外二氧化碳去除设备市场的增长。

欧洲体外二氧化碳去除装置市场预计将占据全球第二大市场份额。这得益于该地区对医疗保健设备的需求不断增长,以及呼吸衰竭等慢性疾病的发病率不断上升。此外,优惠的报销政策、政府对长期医疗保健的投入不断增加以及医疗保健研究基础设施的不断完善,都在提高体外二氧化碳去除装置的使用率。

预计亚太地区体外二氧化碳去除装置市场在预测期内将实现7.3%的最快增长率。这一增长得益于患者群体庞大、人们对急性呼吸衰竭的认识不断提高,以及印度和日本等发展中国家政府医疗保健支出的增加。此外,跨国公司期待在中国等发展中国家投资,从而推动该地区的市场增长。

 

体外二氧化碳去除装置市场区域洞察

Insight Partners 的分析师已详尽阐述了预测期内影响体外二氧化碳去除装置市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美的体外二氧化碳去除装置市场细分和地域分布。

Extracorporeal CO2 Removal Devices Market
  • 获取体外二氧化碳去除装置市场的区域特定数据

体外二氧化碳去除装置市场报告范围

报告属性细节
2024年的市场规模1.125亿
2031年的市场规模1.8436亿
全球复合年增长率(2024-2031)6.4%
史料2021-2023
预测期2025-2031
涵盖的领域按产品
  • 体外二氧化碳装置及耗材
按应用
  • 急性呼吸窘迫综合征
  • 慢性阻塞性肺疾病
按最终用户
  • 医院和诊所
  • 门诊手术中心
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 洁廷
  • ALung Technologies, Inc.
  • 埃斯托
  • NovaLung有限公司
  • 赫莫德克
  • 百特医疗保健
  • 欧元套
  • 利瓦诺瓦
  • 美敦力
  • Xenios股份公司

 

体外二氧化碳去除装置市场参与者密度:了解其对业务动态的影响

体外二氧化碳去除设备市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求的驱动因素包括消费者偏好的演变、技术进步以及对产品优势的认知度的提升。随着需求的增长,企业正在扩展产品线,不断创新以满足消费者需求,并抓住新兴趋势,从而进一步推动市场增长。

市场参与者密度是指特定市场或行业内企业或公司的分布情况。它表明特定市场空间内竞争对手(市场参与者)的数量相对于其规模或总市值而言。

在体外二氧化碳去除装置市场运营的主要公司有:

  1. 洁廷
  2. ALung Technologies, Inc.
  3. 埃斯托
  4. NovaLung有限公司
  5. 赫莫德克
  6. 百特医疗保健

免责声明以上列出的公司没有按照任何特定顺序排列。


Extracorporeal CO2 Removal Devices Market

 

  • 获取体外二氧化碳去除装置市场主要参与者概览

行业发展和未来机遇:

体外二氧化碳去除设备市场预测可以帮助该市场的利益相关者规划其增长战略。以下列出了市场领先企业的一些战略发展:

  • 2022 年 10 月,ALung Technologies 评估了使用 Hemolung 呼吸辅助系统 (RAS) 进行低流量体外二氧化碳去除 (ECCO2R) 作为有创机械通气的替代或辅助手段,用于因慢性阻塞性肺病 (COPD) 急性加重而需要呼吸支持的患者。
  • 2022年3月,美国呼吸健康科技公司Respira Labs推出了Sylvee。这款人工智能驱动的可穿戴肺监测仪利用声共振技术评估肺功能并识别肺容量波动。它可以帮助检测和治疗慢性阻塞性肺病、哮喘和新冠肺炎。
  • 2021 年 5 月,ALung Technologies, Inc. 的下一代 Hemolung RAS 体外二氧化碳去除系统获得 FDA 批准,该系统旨在为急性呼吸衰竭患者提供呼吸支持。
  • 2020年5月,ALung Technologies, Inc.宣布对名为Hemolung RAS的下一代人工肺进行商业开发。

竞争格局和重点公司:

Getinge、ALung Technologies, Inc.、Estor、NovaLung GmbH、Hemodec、Baxter Healthcare、Eurosets、LivaNova、Medtronic 和 Xenios AG 等知名公司均是体外二氧化碳去除设备市场报告中重点介绍的公司。这些公司专注于开发新技术、升级现有产品并拓展业务范围,以满足全球日益增长的消费者需求。

  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
extracorporeal-co2-removal-market-report-deliverables-img1
extracorporeal-co2-removal-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


What was the estimated extracorporeal CO2 removal devices market size in 2024?

The hyperbaric oxygen therapy market was valued at US$ 112.5 million in 2024.

Which segment is dominating the extracorporeal CO2 removal devices market?

The global extracorporeal CO2 removal devices market, based on product is bifurcated into extracorporeal CO2 devices and consumables. The extracorporeal CO2 devices segment held a larger market share in 2022. The consumables segment is anticipated to register a higher CAGR of 7.6% during the forecast period. Based on application, the market is segmented into acute respiratory distress syndrome, chronic obstructive pulmonary disease, and others. The chronic obstructive pulmonary disease segment held the largest market share in 2022. The acute respiratory distress syndrome segment is anticipated to register the highest CAGR of 7.7% during 2022–2030. In terms of end user, the extracorporeal CO2 removal devices market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest extracorporeal CO2 removal devices market share in 2022 and is anticipated to register the highest CAGR of 7.4% during 2022–2030.

What are the growth estimates for the extracorporeal CO2 removal devices market till 2031?

The hyperbaric oxygen therapy market is expected to be valued at US$ 184.36 million by 2031

What are the driving factors for the extracorporeal CO2 removal devices market?

The factors driving the growth of the extracorporeal CO2 removal devices market include the increasing cases of chronic obstructive pulmonary diseases (COPD) and growing geriatric population.

Who are the major players in the extracorporeal CO2 removal devices market?

The extracorporeal CO2 removal devices market majorly consists of the players such as Getinge, ALung Technologies, Inc.; Estor, NovaLung GmbH, Hemodec, Baxter Healthcare, Eurosets, LivaNova, Medtronic, and Xenios AG.

What is extracorporeal CO2 removal devices?

Extracorporeal CO2 removal devices are an efficient therapy for patients with hypercapnic respiratory failure. They can enable doctors and healthcare professionals to improve lung protective ventilation. Extracorporeal CO2 removal devices can remove enough CO2 to reduce alveolar minute ventilation by 50%, significantly reducing the partial pressure of carbon dioxide (PaCO2). Therefore, various advantages of extracorporeal CO2 removal devices are expected to increase the overall market development.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Extracorporeal CO2 Removal Devices Market

  1. Getinge
  2. ALung Technologies, Inc.
  3. Estor
  4. NovaLung GmbH
  5. Hemodec
  6. Baxter Healthcare
  7. Eurosets
  8. LivaNova
  9. Medtronic
  10. Xenios AG
extracorporeal-co2-removal-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.